Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease

Published:2019-03-28 Issue:8 Volume:49 Page:1092-1093
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Targher Giovanni¹^ORCID,Lippi Giuseppe²

Affiliation:

1. Section of Endocrinology, Diabetes and Metabolism; Department of Medicine; University and Azienda Ospedaliera Universitaria Integrata of Verona; Verona Italy

2. Section of Clinical Biochemistry; University and Azienda Ospedaliera Universitaria Integrata of Verona; Verona Italy

Funder

University School of Medicine of Verona

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15208/fullpdf

Reference10 articles.

1. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis;Sansanayudh;Thromb Haemost,2015

2. Nonalcoholic fatty liver disease and mean platelet volume: a systemic review and meta-analysis;Madan;J Clin Gastroenterol,2016

3. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases;Adams;Gut,2017

4. Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume;Abeles;Aliment Pharmacol Ther,2019

5. Genetic and nongenetic determinants of mean platelet volume;Lippi;Blood,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Alcoholic Fatty Liver Disease and Vascular Disease;Current Vascular Pharmacology;2020-12-31

2. Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors’ reply;Alimentary Pharmacology & Therapeutics;2019-03-28